» Articles » PMID: 33742279

Survival of Glioblastoma in Relation to Tumor Location: a Statistical Tumor Atlas of a Population-based Cohort

Overview
Specialty Neurosurgery
Date 2021 Mar 20
PMID 33742279
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Previous studies on the effect of tumor location on overall survival in glioblastoma have found conflicting results. Based on statistical maps, we sought to explore the effect of tumor location on overall survival in a population-based cohort of patients with glioblastoma and IDH wild-type astrocytoma WHO grade II-III with radiological necrosis.

Methods: Patients were divided into three groups based on overall survival: < 6 months, 6-24 months, and > 24 months. Statistical maps exploring differences in tumor location between these three groups were calculated from pre-treatment magnetic resonance imaging scans. Based on the results, multivariable Cox regression analyses were performed to explore the possible independent effect of centrally located tumors compared to known prognostic factors by use of distance from center of the third ventricle to contrast-enhancing tumor border in centimeters as a continuous variable.

Results: A total of 215 patients were included in the statistical maps. Central tumor location (corpus callosum, basal ganglia) was associated with overall survival < 6 months. There was also a reduced overall survival in patients with tumors in the left temporal lobe pole. Tumors in the dorsomedial right temporal lobe and the white matter region involving the left anterior paracentral gyrus/dorsal supplementary motor area/medial precentral gyrus were associated with overall survival > 24 months. Increased distance from center of the third ventricle to contrast-enhancing tumor border was a positive prognostic factor for survival in elderly patients, but less so in younger patients.

Conclusions: Central tumor location was associated with worse prognosis. Distance from center of the third ventricle to contrast-enhancing tumor border may be a pragmatic prognostic factor in elderly patients.

Citing Articles

Emerging Approaches in Glioblastoma Treatment: Modulating the Extracellular Matrix Through Nanotechnology.

Horta M, Soares P, Leite Pereira C, Lima R Pharmaceutics. 2025; 17(2).

PMID: 40006509 PMC: 11859630. DOI: 10.3390/pharmaceutics17020142.


Predicting survival in malignant glioma using artificial intelligence.

Awuah W, Ben-Jaafar A, Roy S, Nkrumah-Boateng P, Tan J, Abdul-Rahman T Eur J Med Res. 2025; 30(1):61.

PMID: 39891313 PMC: 11783879. DOI: 10.1186/s40001-025-02339-3.


Impact of tumor-treating fields on the survival of Japanese patients with newly diagnosed glioblastoma: A multicenter, retrospective cohort study.

Kanamori M, Tsuzuki S, Shibahara I, Saito K, Shimoda Y, Tanaka K Neurooncol Adv. 2024; 6(1):vdae176.

PMID: 39659832 PMC: 11629686. DOI: 10.1093/noajnl/vdae176.


Visualizing the association between the location and prognosis of isocitrate dehydrogenase wild-type glioblastoma: a voxel-wise Cox regression analysis with open-source datasets.

Atsukawa N, Tatekawa H, Ueda D, Oura T, Matsushita S, Horiuchi D Neuroradiology. 2024; .

PMID: 39542911 DOI: 10.1007/s00234-024-03503-y.


The Three Pillars of Glioblastoma: A Systematic Review and Novel Analysis of Multi-Omics and Clinical Data.

De Luca C, Virtuoso A, Papa M, Cirillo G, La Rocca G, Corvino S Cells. 2024; 13(21.

PMID: 39513861 PMC: 11544881. DOI: 10.3390/cells13211754.


References
1.
Adeberg S, Bostel T, Konig L, Welzel T, Debus J, Combs S . A comparison of long-term survivors and short-term survivors with glioblastoma, subventricular zone involvement: a predictive factor for survival?. Radiat Oncol. 2014; 9:95. PMC: 4011838. DOI: 10.1186/1748-717X-9-95. View

2.
Arora I, Gurav M, Rumde R, Dhanavade S, Kadam V, Kurani H . gene promoter methylation and its correlation with clinicopathological parameters in glioblastomas. Neurol India. 2018; 66(4):1106-1114. DOI: 10.4103/0028-3886.236974. View

3.
Capellades J, Teixidor P, Villalba G, Hostalot C, Plans G, Armengol R . Results of a multicenter survey showing interindividual variability among neurosurgeons when deciding on the radicality of surgical resection in glioblastoma highlight the need for more objective guidelines. Clin Transl Oncol. 2016; 19(6):727-734. DOI: 10.1007/s12094-016-1598-6. View

4.
de Witt Hamer P, Hendriks E, Mandonnet E, Barkhof F, Zwinderman A, Duffau H . Resection probability maps for quality assessment of glioma surgery without brain location bias. PLoS One. 2013; 8(9):e73353. PMC: 3765204. DOI: 10.1371/journal.pone.0073353. View

5.
Egger J, Kapur T, Fedorov A, Pieper S, Miller J, Veeraraghavan H . GBM volumetry using the 3D Slicer medical image computing platform. Sci Rep. 2013; 3:1364. PMC: 3586703. DOI: 10.1038/srep01364. View